AI
SKYE icon

AdvisorShares Investments’s Skye Bioscience SKYE Stock Holding History

AdvisorShares Investments’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-88,391
Closed -$250K – 326
2024
Q4 		$250K Sell
88,391
-26,609
-23% -$111K 0.05% 213
2024
Q3 		$450K Buy
115,000
+89,000
+342% +$499K 0.09% 173
2024
Q2 		$210K Buy
+26,000
New +$309K 0.04% 222

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $53.7B AUM 29.47% 1-Year Est. Return

AdvisorShares Investments's SKYE Position: Q1 2025 in Review

AdvisorShares Investments sold out of Skye Bioscience (SKYE) in Q1 2025, closing a stake of 88,391 shares — an estimated $250K sold.

AdvisorShares Investments first reported a position in SKYE in Q2 2024 and held it in 3 quarters. The position peaked at $450K in Q3 2024. 75 funds tracked by Wall St. Rank hold SKYE as of Q1 2025.

  • AdvisorShares Investments reported no remaining Skye Bioscience position as of Q1 2025 after selling out during the quarter.
  • AdvisorShares Investments sold 88,391 Skye Bioscience shares in Q1 2025, an estimated $250K.
  • AdvisorShares Investments first reported a position in Skye Bioscience in Q2 2024 and held it in 3 quarters.
  • AdvisorShares Investments's Skye Bioscience position peaked at $450K in Q3 2024.
  • 75 funds tracked by Wall St. Rank held Skye Bioscience as of Q1 2025.

Based on AdvisorShares Investments's 13F filing for Q1 2025, filed 13 May 2025.